Mining emerging biomedical literature for understanding disease associations in drug discovery

Methods in Molecular Biology

Volumn 1159, Issue , 2014, Pages 171-206

  Rajpal, Deepak K ^a   Qu, Xiaoyan A ^a   Freudenberg, Johannes M ^a   Kumar, Vinod D ^a  

^a NONE

Author keywords

Biomedical literature; Diseases; Drug discovery; Genes; MEDLINE; MeSH; Pathways; PubMed; Trends

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; SIRTUIN 1;

ADAPTIVE IMMUNITY; ARTICLE; BIBLIOMETRICS; BIOAVAILABILITY; BIOMEDICINE; CELL ENERGY; CELLULAR IMMUNITY; DATA MINING; DISEASE ASSOCIATION; DRUG DEVELOPMENT; GENE MAPPING; GENE ONTOLOGY; GENETIC ASSOCIATION; HUMAN; INNATE IMMUNITY; KERATINOCYTE; MEDICAL LITERATURE; METABOLISM; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; TH17 CELL; TRANSCRIPTOMICS; WHITE ADIPOCYTE; ANIMAL; INFORMATION RETRIEVAL; MEDICAL SUBJECT HEADINGS; MEDLINE; PROCEDURES;

ANIMALS; DATA MINING; DRUG DISCOVERY; GENE ONTOLOGY; HUMANS; LITERATURE BASED DISCOVERY; MEDICAL SUBJECT HEADINGS; MEDLINE;

EID: 84922151208     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0709-0_11     Document Type: Article

References (86)

1. Agarwal P, Searls DB (2008) Literature mining in support of drug discovery. Brief Bioinform 9:479-492
2. Agarwal P, Searls DB (2009) Can literature analysis identify innovation drivers in drug discovery? Nat Rev Drug Discov 8:865-878
3. Andrade MA, Valencia A (1997) Automatic annotation for biological sequences by extraction of keywords from MEDLINE abstracts. Development of a prototype system. Proc Int Conf Intell Syst Mol Biol 5:25-32
4. Davis AP, Wiegers TC, Johnson RJ, Lay JM, Lennon-Hopkins K, Saraceni-Richards C, Sciaky D, Murphy CG, Mattingly CJ (2013) Text mining effectively scores and ranks the literature for improving chemical-gene-disease curation at the comparative toxicogenomics database. PLoS One 8:e58201
5. Hanisch D, Fluck J, Mevissen HT, Zimmer R (2003) Playing biology’s name game: identifying protein names in scientific text. Pac Symp Biocomput 403-414
6. Jenssen TK, Laegreid A, Komorowski J, Hovig E (2001) A literature network of human genes for high-throughput analysis of gene expression. Nat Genet 28:21-28
7. Shatkay H, Edwards S, Wilbur WJ, Boguski M (2000) Genes, themes and microarrays: using information retrieval for large-scale gene analysis. Proc Int Conf Intell Syst Mol Biol 8:317-328
8. Yandell MD, Majoros WH (2002) Genomics and natural language processing. Nat Rev Genet 3:601-610
9. van Haagen HH, ‘t Hoen PA, de Morrée A, van Roon-Mom WM, Peters DJ, Roos M, Mons B, van Ommen GJ, Schuemie MJ (2011) In silico discovery and experimental validation of new protein-protein interactions. Proteomics 11:843-853
10. van Haagen HH, ‘t Hoen PA, Mons B, Schultes EA (2013) Generic information can retrieve known biological associations: implications for biomedical knowledge discovery. PLoS One 8:e78665
11. Srinivasan P, Hristovski D (2004) Distilling conceptual connections from MeSH cooccurrences. Stud Health Technol Inform 107:808-812
12. O’Brien PE (2010) Bariatric surgery: mechanisms, indications and outcomes. J Gastroenterol Hepatol 25:1358-1365
13. World Health Organization (2012) Obesity and overweight-fact sheet no. 311. WHO Media Centre Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs311/en/
14. Haslam DW, James WP (2005) Obesity. Lancet 366:1197-1209
15. Foxx-Orenstein AE (2010) Gastrointestinal symptoms and diseases related to obesity: an overview. Gastroenterol Clin North Am 39: 23-37
16. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W (2009) Annual medical spending attributable to obesity: payer-and service-specifi c estimates. Health Aff (Millwood) 28:W822-W831
17. Courcoulas AP, Christian NJ, Belle SH, Berk PD, Flum DR, Garcia L, Horlick M, Kalarchian MA, King WC, Mitchell JE, Patterson EJ, Pender JR, Pomp A, Pories WJ, Thirlby RC, Yanovski SZ, Wolfe BM (2013) Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA 310(22):2416-2425
18. Fontana MA, Wohlgemuth SD (2010) The surgical treatment of metabolic disease and morbid obesity. Gastroenterol Clin North Am 39:125-133
19. Rubino F, Schauer PR, Kaplan LM, Cummings DE (2010) Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 61:393-411
20. Derosa G, Maffioli P (2012) Anti-obesity drugs: a review about their effects and their safety. Expert Opin Drug Saf 11:459-471
21. Kaplan LM (2010) Pharmacologic therapies for obesity. Gastroenterol Clin North Am 39:69-79
22. O’Neil PM, Smith SR, Weissman NJ, Fidler MC, Sanchez M, Zhang J, Raether B, Anderson CM, Shanahan WR (2012) Randomized placebo- controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring) 20:1426-1436
23. Wong D, Sullivan K, Heap G (2012) The pharmaceutical market for obesity therapies. Nat Rev Drug Discov 11:669-670
24. Kim GW, Lin JE, Blomain ES, Waldman SA (2013) New advances in models and strategies for developing anti-obesity drugs. Expert Opin Drug Discov 8:655-671
25. Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP, Krueger GG (2005) Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 141:1527-1534
26. Naldi L, Addis A, Chimenti S, Giannetti A, Picardo M, Tomino C, Maccarone M, Chatenoud L, Bertuccio P, Caggese E, Cuscito R (2008) Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project. Dermatology 217:365-373
27. Henseler T, Christophers E (1995) Disease concomitance in psoriasis. J Am Acad Dermatol 32:982-986
28. Gottlieb AB, Chao C, Dann F (2008) Psoriasis comorbidities. J Dermatolog Treat 19:5-21
29. Gottlieb AB, Dann F, Menter A (2008) Psoriasis and the metabolic syndrome. J Drugs Dermatol 7:563-572
30. Hossler EW, Maroon MS, Mowad CM (2011) Gastric bypass surgery improves psoriasis. J Am Acad Dermatol 65:198-200
31. Farias MM, Achurra P, Boza C, Vega A, de la Cruz C (2012) Psoriasis following bariatric surgery: clinical evolution and impact on quality of life on 10 patients. Obes Surg 22:877-880
32. Krueger G, Ellis CN (2005) Psoriasis-recent advances in understanding its pathogenesis and treatment. J Am Acad Dermatol 53:S94-S100
33. Kurd SK, Gelfand JM (2009) The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 60:218-224
34. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T (2004) Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 9:136-139
35. Gudjonsson JE, Elder JT (2007) Psoriasis: epidemiology. Clin Dermatol 25:535-546
36. Elder JT (2009) Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis. Genes Immun 10:201-209
37. Gudjonsson JE (2007) Analysis of global gene expression and genetic variation in psoriasis. J Am Acad Dermatol 57:365
38. Shaiq PA, Stuart PE, Latif A, Schmotzer C, Kazmi AH, Khan MS, Azam M, Tejasvi T, Voorhees JJ, Raja GK, Elder JT, Qamar R, Nair RP (2013) Genetic associations of psoriasis in a Pakistani population. Br J Dermatol 169:406-411
39. Stuart PE, Nair RP, Hiremagalore R, Kullavanijaya P, Kullavanijaya P, Tejasvi T, Lim HW, Voorhees JJ, Elder JT (2010) Comparison of MHC class I risk haplotypes in Thai and Caucasian psoriatics shows locus heterogeneity at PSORS1. Tissue Antigens 76:387-397
40. Shah KN (2013) Diagnosis and treatment of pediatric psoriasis: current and future. Am J Clin Dermatol 14(3):195-213
41. Gan EY, Chong WS, Tey HL (2013) Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents. BioDrugs 27(4):359-373
42. Kupetsky EA, Mathers AR, Ferris LK (2013) Anti-cytokine therapy in the treatment of psoriasis. Cytokine 61:704-712
43. Davis SA, Feldman SR (2013) Combination therapy for psoriasis in the United States. J Drugs Dermatol 12:546-550
44. Mudigonda P, Mudigonda T, Feneran AN, Alamdari HS, Sandoval L, Feldman SR (2012) Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis. Dermatol Online J 18:1
45. Dommasch E, Gelfand JM (2009) Is there truly a risk of lymphoma from biologic therapies? Dermatol Ther 22:418-430
46. Kamangar F, Neuhaus IM, Koo JY (2012) An evidence-based review of skin cancer rates on biologic therapies. J Dermatolog Treat 23: 305-315
47. Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, Giannetti A, Girolomoni G (2007) Prevalence of metabolic syndrome in patients with psoriasis: a hospital- based case-control study. Br J Dermatol 157:68-73
48. Langan SM, Seminara NM, Shin DB, Troxel AB, Kimmel SE, Mehta NN, Margolis DJ, Gelfand JM (2012) Prevalence of metabolic syndrome in patients with psoriasis: a population- based study in the United Kingdom. J Invest Dermatol 132:556-562
49. Davidovici BB, Sattar N, Prinz J, Puig L, Emery P, Barker JN, van de Kerkhof P, Stahle M, Nestle FO, Girolomoni G, Krueger JG (2010) Psoriasis and systemic infl ammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 130:1785-1796
50. Azfar RS, Seminara NM, Shin DB, Troxel AB, Margolis DJ, Gelfand JM (2012) Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis. Arch Dermatol 148:995-1000
51. Higa-Sansone G, Szomstein S, Soto F, Brasecsco O, Cohen C, Rosenthal RJ (2004) Psoriasis remission after laparoscopic Rouxen-Y gastric bypass for morbid obesity. Obes Surg 14:1132-1134
52. Gisondi P, Del GM, Di Francesco V, Zamboni M, Girolomoni G (2008) Weight loss improves the response of obese patients with moderateto- severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. Am J Clin Nutr 88:1242-1247
53. Glossmann H, Reider N (2013) A marriage of two “Methusalem” drugs for the treatment of psoriasis?: arguments for a pilot trial with metformin as add-on for methotrexate. Dermatoendocrinol 5:252-263
54. Fiehn C (2010) Methotrexate transport mechanisms: the basis for targeted drug delivery and ss-folate-receptor-specific treatment. Clin Exp Rheumatol 28:S40-S45
55. Ahlehoff O, Skov L, Gislason G, Lindhardsen J, Kristensen SL, Iversen L, Lasthein S, Gniadecki R, Dam TN, Torp-Pedersen C, Hansen PR (2013) Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study. J Intern Med 273:197-204
56. Perera GK, Di MP, Nestle FO (2012) Psoriasis. Annu Rev Pathol 7:385-422
57. Tian S, Krueger JG, Li K, Jabbari A, Brodmerkel C, Lowes MA, Suarez-Farinas M (2012) Metaanalysis derived (MAD) transcriptome of psoriasis defines the “core” pathogenesis of disease. PLoS One 7:e44274
58. Suarez-Farinas M, Li K, Fuentes-Duculan J, Hayden K, Brodmerkel C, Krueger JG (2012) Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J Invest Dermatol 132:2552-2564
59. Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, Chetvernin V, Church DM, Dicuccio M, Edgar R, Federhen S, Feolo M, Geer LY, Helmberg W, Kapustin Y, Khovayko O, Landsman D, Lipman DJ, Madden TL, Maglott DR, Miller V, Ostell J, Pruitt KD, Schuler GD, Shumway M, Sequeira E, Sherry ST, Sirotkin K, Souvorov A, Starchenko G, Tatusov RL, Tatusova TA, Wagner L, Yaschenko E (2008) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 36:D13-D21
60. Mitchell JA, Aronson AR, Mork JG, Folk LC, Humphrey SM, Ward JM (2003) Gene indexing: characterization and analysis of NLM’s GeneRIFs. AMIA Annu Symp Proc 460-464
61. Freudenberg JM, Joshi VK, Hu Z, Medvedovic M (2009) CLEAN: CLustering Enrichment ANalysis. BMC Bioinformatics 10:234
62. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80
63. Leibel RL (2008) Molecular physiology of weight regulation in mice and humans. Int J Obes (Lond) 32 Suppl 7: S98-S108
64. Valentino MA, Lin JE, Waldman SA (2010) Central and peripheral molecular targets for antiobesity pharmacotherapy. Clin Pharmacol Ther 87:652-662
65. Ruderman NB, Carling D, Prentki M, Cacicedo JM (2013) AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest 123: 2764-2772
66. Lindholm CR, Ertel RL, Bauwens JD, Schmuck EG, Mulligan JD, Saupe KW (2013) A high-fat diet decreases AMPK activity in multiple tissues in the absence of hyperglycemia or systemic infl ammation in rats. J Physiol Biochem 69:165-175
67. Pacher P, Kunos G (2013) Modulating the endocannabinoid system in human health and disease-successes and failures. FEBS J 280: 1918-1943
68. Ionut V, Burch M, Youdim A, Bergman RN (2013) Gastrointestinal hormones and bariatric surgery-induced weight loss. Obesity (Silver Spring) 21:1093-1103
69. Mells JE, Anania FA (2013) The role of gastrointestinal hormones in hepatic lipid metabolism. Semin Liver Dis 33:343-357
70. Huffmeier U, Uebe S, Ekici AB, Bowes J, Giardina E, Korendowych E, Juneblad K, Apel M, McManus R, Ho P, Bruce IN, Ryan AW, Behrens F, Lascorz J, Bohm B, Traupe H, Lohmann J, Gieger C, Wichmann HE, Herold C, Steffens M, Klareskog L, Wienker TF, Fitzgerald O, Alenius GM, McHugh NJ, Novelli G, Burkhardt H, Barton A, Reis A (2010) Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet 42:996-999
71. Bohm B, Burkhardt H, Uebe S, Apel M, Behrens F, Reis A, Huffmeier U (2012) Identification of low-frequency TRAF3IP2 coding variants in psoriatic arthritis patients and functional characterization. Arthritis Res Ther 14:R84
72. Benson JM, Sachs CW, Treacy G, Zhou H, Pendley CE, Brodmerkel CM, Shankar G, Mascelli MA (2011) Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab. Nat Biotechnol 29:615-624
73. Yawalkar N, Karlen S, Hunger R, Brand CU, Braathen LR (1998) Expression of interleukin- 12 is increased in psoriatic skin. J Invest Dermatol 111:1053-1057
74. Martin DA, Towne JE, Kricorian G, Klekotka P, Gudjonsson JE, Krueger JG, Russell CB (2013) The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Invest Dermatol 133:17-26
75. Gisondi P, Girolomoni G, Sampogna F, Tabolli S, Abeni D (2005) Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. Eur J Dermatol 15:279-283
76. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496-509
77. Debets R, Hegmans JP, Croughs P, Troost RJ, Prins JB, Benner R, Prens EP (1997) The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis. J Immunol 158:2955-2963
78. Groves RW, Kapahi P, Barker JN, Haskard DO, MacDonald DM (1995) Detection of circulating adhesion molecules in erythrodermic skin disease. J Am Acad Dermatol 32:32-36
79. Freudenberg JM, Rajpal N, Way JM, Magid-Slav M, Rajpal DK (2013) Gastrointestinal weight-loss surgery: glimpses at the molecular level. Drug Discov Today 18(13-14):625-636
80. Hurle MR, Yang L, Xie Q, Rajpal DK, Sanseau P, Agarwal P (2013) Computational drug repositioning: from data to therapeutics. Clin Pharmacol Ther 93:335-341
81. Buchan NS, Rajpal DK, Webster Y, Alatorre C, Gudivada RC, Zheng C, Sanseau P, Koehler J (2011) The role of translational bioinformatics in drug discovery. Drug Discov Today 16: 426-434
82. Hopkins AL, Groom CR (2002) The druggable genome. Nat Rev Drug Discov 1:727-730
83. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106:9362-9367
84. Zhang Y, De S, Garner JR, Smith K, Wang SA, Becker KG (2010) Systematic analysis, comparison, and integration of disease based human genetic association data and mouse genetic phenotypic information. BMC Med Genomics 3:1
85. Eppig JT, Blake JA, Bult CJ, Kadin JA, Richardson JE (2012) The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse. Nucleic Acids Res 40:D881-D886
86. Carlberg C, Molnar F (2012) Current status of vitamin D signaling and its therapeutic applications. Curr Top Med Chem 12:528-547